AML characterized by <i>FLT3</i> internal tandem duplication (<i>FLT3</i> ITD) is typically associated with an aggressive clinical course with rapid progression, relapse, and short overall survival in the absence of transplantation. Here, FLT3 is linked to acute myeloid leukemia.